Do I need an in-person exam for Strattera?

In recent years, telehealth has transformed how patients access ADHD treatment. While much attention focuses on stimulant medications like Adderall and Ritalin (which face stricter regulations), non-stimulant options like Strattera (atomoxetine) offer an alternative pathway with fewer regulatory hurdles. This comprehensive guide explains the current telehealth landscape for non-stimulant ADHD medications, focusing on what patients need to know about getting Strattera prescribed online in 2025.

Can I Get Strattera Through Telehealth?

Yes, you can get Strattera (atomoxetine) prescribed through telehealth in all 50 states. Since Strattera is not a controlled substance, it’s not subject to the special DEA restrictions that apply to stimulants. This makes it significantly easier to access via telehealth platforms compared to medications like Adderall or Ritalin.

When using telehealth for Strattera, you’ll typically:

• Complete an online assessment
• Have a video consultation with a licensed provider
• Receive your prescription electronically to your preferred pharmacy
• Schedule follow-up appointments to monitor your progress

Platforms like Klarity Health connect patients with licensed providers who can evaluate ADHD symptoms, discuss treatment options including Strattera, and provide ongoing care—all virtually.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Understanding Non-Stimulant ADHD Medications

Strattera works differently from stimulant medications:

Unlike stimulants that work immediately, Strattera typically takes 4-6 weeks to reach full effectiveness. However, its non-controlled status means fewer regulatory hurdles for both patients and providers.

Federal Regulations for Telehealth ADHD Treatment

The regulatory landscape for telehealth ADHD treatment has several key components:

DEA Rules and the Ryan Haight Act

For non-stimulant medications like Strattera:

• No in-person requirement: The Ryan Haight Act’s in-person exam rule only applies to controlled substances
• No special DEA registration needed: While providers need a standard DEA registration to prescribe controlled substances, Strattera doesn’t require this special authorization
• No federal restrictions on refills: Unlike Schedule II stimulants that require a new prescription each month, Strattera can have refills

For context, stimulant medications are currently operating under a temporary DEA waiver (through December 31, 2025) that allows telehealth prescribing without an in-person visit. However, this flexibility doesn’t affect Strattera, which has always been prescribable via telehealth.

Prescription Drug Monitoring Programs (PDMPs)

Since Strattera is not a controlled substance:

• It’s not tracked in state PDMPs
• Providers aren’t legally required to check PDMP databases before prescribing it
• However, responsible telehealth providers may still check your medication history as part of a thorough evaluation

State-by-State Telehealth Rules for Non-Stimulant ADHD Medications

While federal law doesn’t restrict telehealth prescribing of Strattera, state laws can vary:

States with Minimal Restrictions

Most states, including California, Texas, Georgia, and Pennsylvania, have no special restrictions on telehealth prescribing of non-controlled substances like Strattera. In these states:

• A video telehealth visit is sufficient for evaluation and prescribing
• No in-person exam is required at any point
• Follow-ups can continue via telehealth indefinitely

States with Periodic In-Person Requirements

A few states require periodic in-person exams for ongoing telehealth treatment, but often with exemptions for mental health care:

• Alabama: Generally requires an in-person exam at least once every 12 months for ongoing telehealth treatment, but this requirement is waived for mental health services, including ADHD treatment

• New Hampshire: Recently updated its laws to require only an annual evaluation (which can be via telehealth) for controlled substance prescribing. For non-controlled medications like Strattera, there are no special requirements beyond standard of care.

States with Special Prescriber Restrictions

Some states limit who can prescribe certain ADHD medications:

• Texas, Georgia, and Alabama: Nurse practitioners and physician assistants face significant restrictions on prescribing controlled stimulants, though these restrictions don’t apply to non-stimulants like Strattera

• Florida: NPs must have a collaborative agreement with a physician but can prescribe non-stimulants under that agreement

In all states, physicians (MDs and DOs) can prescribe Strattera via telehealth as long as they’re licensed in your state and following standard practice guidelines.

The Telehealth ADHD Evaluation Process

When seeking Strattera through telehealth, expect a comprehensive evaluation process:

Initial Assessment

1. Online screening: Complete questionnaires about your symptoms, medical history, and previous treatments

2. Video consultation: Meet with a provider who will:

• Review your symptoms using DSM-5 diagnostic criteria
• Discuss your medical history and any contraindications
• Consider alternative diagnoses
• Explain treatment options, including Strattera

1. Treatment plan: If appropriate, the provider will:

• Prescribe Strattera with instructions
• Discuss potential side effects
• Outline a follow-up schedule
• Address any questions or concerns

At Klarity Health, providers conduct thorough evaluations to ensure accurate diagnoses and appropriate treatment recommendations, with transparent pricing and both insurance and self-pay options.

Follow-Up Care

For Strattera, follow-up appointments are crucial:

• Initial follow-up typically within 2-4 weeks
• Regular monitoring to assess effectiveness and side effects
• Dosage adjustments as needed (Strattera often starts at a lower dose and increases gradually)
• Ongoing care to ensure the medication continues to work effectively

Patient Eligibility and Considerations

Who is a Good Candidate for Telehealth Strattera Treatment?

Strattera via telehealth may be ideal for patients who:

• Have confirmed ADHD diagnosis or symptoms consistent with ADHD
• Prefer a non-stimulant approach or haven’t responded well to stimulants
• Have contraindications to stimulants (e.g., certain heart conditions, history of substance abuse)
• Want medication with less risk of dependency
• Need ongoing refills with fewer regulatory hurdles

Contraindications and Red Flags

Providers will screen for conditions that might make Strattera unsafe, including:

• Narrow-angle glaucoma
• Current or recent use of MAO inhibitors (within 14 days)
• Severe liver problems
• Certain heart conditions
• History of suicidal thoughts (Strattera carries an FDA warning about increased suicide risk, especially in young people)

Documentation Requirements

Expect to provide:

• Valid ID and proof of residence in the state where the provider is licensed
• Medical history, including any previous ADHD treatment
• List of current medications
• Information about your symptoms in different settings (work, home, social)

Common Misconceptions About Telehealth ADHD Treatment

Myth: ‘Online ADHD prescriptions are automatic or easy to get’

Reality: Legitimate telehealth providers conduct thorough evaluations following the same diagnostic standards as in-person care. If a service guarantees medication or has minimal screening, that’s a red flag.

Myth: ‘Non-stimulants aren’t effective for ADHD’

Reality: While stimulants are often first-line treatment, Strattera can be very effective for many patients, particularly those who experience side effects from stimulants or have concerns about stimulant use. It works differently and may take longer to show results, but can provide 24-hour symptom control once established.

Myth: ‘Telehealth prescriptions won’t be filled by local pharmacies’

Reality: Pharmacies routinely fill electronic prescriptions from licensed telehealth providers. Since Strattera isn’t controlled, it generally faces less scrutiny than stimulant prescriptions.

Tips for Telehealth ADHD Patients

1. Choose reputable platforms that emphasize comprehensive care and employ licensed providers with ADHD expertise

2. **Be thorough

Source:

• https://www.fiercehealthcare.com/regulatory/dea-finalizes-one-year-extension-controlled-substance-prescribing-telehealth-punts-final#:~:text=The%20Drug%20Enforcement%20Administration%20,Federal%20Register%20on%20Friday%20night
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=visit,examination%20through%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.fiercehealthcare.com/regulatory/dea-finalizes-one-year-extension-controlled-substance-prescribing-telehealth-punts-final#:~:text=The%20%E2%80%9CThird%20Temporary%20Extension%20of,14
• https://www.medicalnewstoday.com/articles/drugs-is-strattera-a-controlled-substance#:~:text=Strattera%20,such%20as%20mental%20health%20issues
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.rxagent.co/blog/telehealth-compliance-trap#:~:text=The%20,False%20Hope
• https://www.techtarget.com/virtualhealthcare/news/366616019/Telehealth-prescribing-flexibility-extended-through-2025#:~:text=Image%20filo%2FDigitalVision%20Vectors%20via%20G,The
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Extend%20natlawreview,before%20issuing%20a%20dangerous%20drug
• https://www.rxagent.co/blog/telehealth-compliance-trap#:~:text=,specifically%20for%20chronic%20pain%20treatment